Development and validation of chest CT-based imaging biomarkers for early stage COVID-19 screening.
Ontology highlight
ABSTRACT: Coronavirus Disease 2019 (COVID-19) is currently a global pandemic, and early screening is one of the key factors for COVID-19 control and treatment. Here, we developed and validated chest CT-based imaging biomarkers for COVID-19 patient screening from two independent hospitals with 419 patients. We identified the vasculature-like signals from CT images and found that, compared to healthy and community acquired pneumonia (CAP) patients, COVID-19 patients display a significantly higher abundance of these signals. Furthermore, unsupervised feature learning led to the discovery of clinical-relevant imaging biomarkers from the vasculature-like signals for accurate and sensitive COVID-19 screening that have been double-blindly validated in an independent hospital (sensitivity: 0.941, specificit
SUBMITTER: Liu XP
PROVIDER: S-EPMC9533142 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA